Displaying results 1 - 4 of 4
Clear search
Five Alarm Bio and Proteotype collaborate on new anti-aging approach
Five Alarm Bio Ltd and Proteotype Diagnostics Ltd have been awarded a highly-competitive collaborative grant from the Babraham Research Campus from the Campus Innovation Award programme, to develop and test novel biomarkers for cellular senescence.
Seed investment to further advance our pioneering antiaging research
Five Alarm Bio writes...we are delighted to announce the close of our seed investment to further advance our pioneering antiaging research.
Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment
Cambridge, UK - Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced today it has completed a seed investment round, raising over £500K GBP to further enable its pioneering research.
Five Alarm Bio in the Press
Five Alarm Bio has anti-ageing drug agenda firmly in its sights